Literature DB >> 18455093

Changes in HIV testing policies and the implications for women.

Suzanne Maman, Elizabeth King.   

Abstract

The US Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) together with the Joint United Nations Programme on HIV/AIDS (UNAIDS) recently released new guidelines for HIV testing in health care settings. Both sets of guidelines recommend eliminating individual informed consent in favor of an opt-out approach that requires clients to actively decline the HIV test after a pretest information session. The revised guidelines also recommend reducing the amount of counseling that accompanies the HIV test. Women are more likely than men to be affected by efforts to expand access to HIV testing in health care settings because of women's increased vulnerability to HIV and greater contact with the health care system. Women may also be more susceptible to changes to the consent and counseling process for HIV testing because of their marginalized social status in many settings. More research is needed to document women's experiences with provider-initiated, opt-out HIV testing. Understanding women's experiences will help to formulate feasible and effective strategies to support women and ensure they gain access to HIV treatment services.

Entities:  

Mesh:

Year:  2008        PMID: 18455093     DOI: 10.1016/j.jmwh.2007.11.001

Source DB:  PubMed          Journal:  J Midwifery Womens Health        ISSN: 1526-9523            Impact factor:   2.388


  13 in total

1.  An offer you can't refuse? Provider-initiated HIV testing in antenatal clinics in rural Malawi.

Authors:  Nicole Angotti; Kim Yi Dionne; Lauren Gaydosh
Journal:  Health Policy Plan       Date:  2010-11-02       Impact factor: 3.344

2.  The complexity of consent: women's experiences testing for HIV at an antenatal clinic in Durban, South Africa.

Authors:  Allison K Groves; Suzanne Maman; Sibekezelo Msomi; Nduduzo Makhanya; Dhayendre Moodley
Journal:  AIDS Care       Date:  2010-05

3.  A critical assessment of the WHO responsiveness tool: lessons from voluntary HIV testing and counselling services in Kenya.

Authors:  Mercy K Njeru; Astrid Blystad; Isaac K Nyamongo; Knut Fylkesnes
Journal:  BMC Health Serv Res       Date:  2009-12-22       Impact factor: 2.655

4.  Is 'Opt-Out HIV Testing' a real option among pregnant women in rural districts in Kenya?

Authors:  Opondo Awiti Ujiji; Birgitta Rubenson; Festus Ilako; Gaetano Marrone; David Wamalwa; Gilbert Wangalwa; Anna Mia Ekström
Journal:  BMC Public Health       Date:  2011-03-08       Impact factor: 3.295

5.  Practicing provider-initiated HIV testing in high prevalence settings: consent concerns and missed preventive opportunities.

Authors:  Mercy K Njeru; Astrid Blystad; Elizabeth H Shayo; Isaac K Nyamongo; Knut Fylkesnes
Journal:  BMC Health Serv Res       Date:  2011-04-21       Impact factor: 2.655

6.  Consequences of missed opportunities for HIV testing during pregnancy and delayed diagnosis for Mexican women, children and male partners.

Authors:  Tamil Kendall
Journal:  PLoS One       Date:  2014-11-05       Impact factor: 3.240

Review 7.  Next-generation sequencing in understanding complex neurological disease.

Authors:  Adam E Handel; Giulio Disanto; Sreeram V Ramagopalan
Journal:  Expert Rev Neurother       Date:  2013-02       Impact factor: 4.618

Review 8.  HIV testing and care in Burkina Faso, Kenya, Malawi and Uganda: ethics on the ground.

Authors:  Carla Makhlouf Obermeyer; Sarah Bott; Ron Bayer; Alice Desclaux; Rachel Baggaley
Journal:  BMC Int Health Hum Rights       Date:  2013-01-23

9.  Couple experiences of provider-initiated couple HIV testing in an antenatal clinic in Lusaka, Zambia: lessons for policy and practice.

Authors:  Maurice Musheke; Virginia Bond; Sonja Merten
Journal:  BMC Health Serv Res       Date:  2013-03-14       Impact factor: 2.655

10.  Pregnant women's experiences of routine counselling and testing for HIV in Eastern Uganda: a qualitative study.

Authors:  Joseph Rujumba; Stella Neema; James K Tumwine; Thorkild Tylleskär; Harald K Heggenhougen
Journal:  BMC Health Serv Res       Date:  2013-05-24       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.